BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mustonen EK, Lee SML, Nieß H, Schwab M, Pantsar T, Burk O. Identification and characterization of novel splice variants of human farnesoid X receptor. Arch Biochem Biophys 2021;705:108893. [PMID: 33930378 DOI: 10.1016/j.abb.2021.108893] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Guo Y, Xie G, Zhang X. Role of FXR in Renal Physiology and Kidney Diseases. IJMS 2023;24:2408. [DOI: 10.3390/ijms24032408] [Reference Citation Analysis]
2 Rausch M, Samodelov SL, Visentin M, Kullak-Ublick GA. The Farnesoid X Receptor as a Master Regulator of Hepatotoxicity. Int J Mol Sci 2022;23. [PMID: 36430444 DOI: 10.3390/ijms232213967] [Reference Citation Analysis]
3 Wang Z, Pang J, Wang L, Dong Q, Jin D. CEBPB regulates the bile acid receptor FXR to accelerate colon cancer progression by modulating aerobic glycolysis. J Clin Lab Anal 2022;:e24703. [PMID: 36129029 DOI: 10.1002/jcla.24703] [Reference Citation Analysis]